Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dario Health Corp (DRIO)

Dario Health Corp (DRIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 237,234
  • Shares Outstanding, K 16,509
  • Annual Sales, $ 7,580 K
  • Annual Income, $ -29,450 K
  • 60-Month Beta 1.32
  • Price/Sales 28.61
  • Price/Cash Flow N/A
  • Price/Book 1.83
Trade DRIO with:

Options Overview

Details
  • Implied Volatility 98.15%
  • Historical Volatility 67.84%
  • IV Percentile 37%
  • IV Rank 19.01%
  • IV High 172.70% on 03/30/21
  • IV Low 80.65% on 08/05/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 2,121
  • Volume Avg (30-Day) 241
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 1,438
  • Open Int (30-Day) 917

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.84
  • Number of Estimates 2
  • High Estimate -0.67
  • Low Estimate -1.00
  • Prior Year -0.71
  • Growth Rate Est. (year over year) -18.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.25 +40.20%
on 08/18/21
14.62 -1.71%
on 09/17/21
+3.81 (+36.08%)
since 08/17/21
3-Month
10.02 +43.41%
on 08/17/21
23.80 -39.62%
on 06/24/21
-7.56 (-34.47%)
since 06/17/21
52-Week
10.01 +43.56%
on 10/30/20
31.85 -54.88%
on 02/16/21
-3.04 (-17.46%)
since 09/17/20

Most Recent Stories

More News
InvestorNewsBreaks DarioHealth Corp. (NASDAQ: DRIO) Exec Featured Speaker at American Health Insurance Plans National Conference

(MENAFN - Investor Brand Network) DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, has announced that chief medical officer Dr. Omar Manejwala will participate in the upcoming...

DRIO : 14.37 (+9.44%)
DarioHealth Chief Medical Officer Dr. Omar Manejwala to Speak at American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. , will present at the annual American...

DRIO : 14.37 (+9.44%)
DarioHealth Chosen by Northeast Regional Employer

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics...

DRIO : 14.37 (+9.44%)
InvestorNewsBreaks DarioHealth Corp. (NASDAQ: DRIO) Signs Behavioral Health Services Contract, Continues Growth in Employer Market

(MENAFN - Investor Brand Network)

DRIO : 14.37 (+9.44%)
DarioHealth Selected by Another Employer for Behavioral Health Services

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health...

DRIO : 14.37 (+9.44%)
DarioHealth Chosen by Regional Primary Care Provider PeopleOne Health as its Digital Behavioral Health Partner

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has been selected by regional primary care provider PeopleOne Health...

DRIO : 14.37 (+9.44%)
Avoid These 3 Stocks

The stock market's rebound to new highs is masking weakness under the surface. The POWR Ratings can help you identify weak stocks as the list is updated daily with upgrades and downgrades. Let’s shift...

ALF : 7.52 (+1.35%)
EYES : 3.43 (-2.56%)
DRIO : 14.37 (+9.44%)
DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial...

DRIO : 14.37 (+9.44%)
DarioHealth Presents New Study Demonstrating Significant Clinical Impact of Personalized Digital Interventions Based on Real-Time Data

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists...

DRIO : 14.37 (+9.44%)
DarioHealth to Report Second Quarter 2021 Results on Monday, August 16

/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended on , and host...

DRIO : 14.37 (+9.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DarioHealth Corp. creates mobile and digital tools. The company's product the Dario(TM) Smart Diabetes Management Solution, is a platform for diabetes management which combines blood glucose meter, native smart phone app, website portal and treatment tools to users living with diabetes, their doctors...

See More

Key Turning Points

3rd Resistance Point 16.32
2nd Resistance Point 15.47
1st Resistance Point 14.92
Last Price 14.37
1st Support Level 13.52
2nd Support Level 12.67
3rd Support Level 12.12

See More

52-Week High 31.85
Fibonacci 61.8% 23.51
Fibonacci 50% 20.93
Fibonacci 38.2% 18.35
Last Price 14.37
52-Week Low 10.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar